107 related articles for article (PubMed ID: 24636244)
1. Spectinamides: a challenge, a proof, and a suggestion.
Viveiros M; Pieroni M
Trends Microbiol; 2014 Apr; 22(4):170-1. PubMed ID: 24636244
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant tuberculosis: a new shot on goal.
Nathan C
Nat Med; 2014 Feb; 20(2):121-3. PubMed ID: 24504402
[No Abstract] [Full Text] [Related]
3. Antibacterial drugs: Redesigned antibiotic combats drug-resistant tuberculosis.
Cully M
Nat Rev Drug Discov; 2014 Apr; 13(4):256. PubMed ID: 24658308
[No Abstract] [Full Text] [Related]
4. Tuberculosis: Drug discovery goes au naturel.
Barry CE
Nature; 2014 Feb; 506(7489):436-7. PubMed ID: 24572417
[No Abstract] [Full Text] [Related]
5. Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux.
Lee RE; Hurdle JG; Liu J; Bruhn DF; Matt T; Scherman MS; Vaddady PK; Zheng Z; Qi J; Akbergenov R; Das S; Madhura DB; Rathi C; Trivedi A; Villellas C; Lee RB; Rakesh ; Waidyarachchi SL; Sun D; McNeil MR; Ainsa JA; Boshoff HI; Gonzalez-Juarrero M; Meibohm B; Böttger EC; Lenaerts AJ
Nat Med; 2014 Feb; 20(2):152-158. PubMed ID: 24464186
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
[TBL] [Abstract][Full Text] [Related]
7. Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design.
Pieroni M; Wan B; Zuliani V; Franzblau SG; Costantino G; Rivara M
Eur J Med Chem; 2015 Jul; 100():44-9. PubMed ID: 26071857
[TBL] [Abstract][Full Text] [Related]
8. [Where does the development of new antituberculotics go? Part 2 - in vitro evaluation].
Waisser K
Ceska Slov Farm; 2014 Feb; 63(1):13-6. PubMed ID: 24568332
[TBL] [Abstract][Full Text] [Related]
9. Nontoxic Metal-Cyclam Complexes, a New Class of Compounds with Potency against Drug-Resistant Mycobacterium tuberculosis.
Yu M; Nagalingam G; Ellis S; Martinez E; Sintchenko V; Spain M; Rutledge PJ; Todd MH; Triccas JA
J Med Chem; 2016 Jun; 59(12):5917-21. PubMed ID: 27214150
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
[No Abstract] [Full Text] [Related]
11. Drug-resistant tuberculosis: what do we do now?
Telenti A; Iseman M
Drugs; 2000 Feb; 59(2):171-9. PubMed ID: 10730543
[TBL] [Abstract][Full Text] [Related]
12. Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance Contributions.
Liu J; Bruhn DF; Lee RB; Zheng Z; Janusic T; Scherbakov D; Scherman MS; Boshoff HI; Das S; Rakesh ; Waidyarachchi SL; Brewer TA; Gracia B; Yang L; Bollinger J; Robertson GT; Meibohm B; Lenaerts AJ; Ainsa J; Böttger EC; Lee RE
ACS Infect Dis; 2017 Jan; 3(1):72-88. PubMed ID: 28081607
[TBL] [Abstract][Full Text] [Related]
13. Nomenclature of drug-resistant tuberculosis.
Udwadia ZF; Amale RA; Ajbani KK; Rodrigues CS
Lancet Infect Dis; 2013 Nov; 13(11):917. PubMed ID: 24156895
[No Abstract] [Full Text] [Related]
14. A Collaborative Approach for "ReSeq-ing" Mycobacterium tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers.
Schito M; Dolinger DL
EBioMedicine; 2015 Oct; 2(10):1262-5. PubMed ID: 26629499
[No Abstract] [Full Text] [Related]
15. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Chakraborty S; Rhee KY
Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396
[TBL] [Abstract][Full Text] [Related]
16. Drug-resistant tuberculosis: reality and potential threat.
Lalloo UG
Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
[No Abstract] [Full Text] [Related]
17. Drug-resistant tuberculosis.
Böttger EC
Lancet; 2001 Apr; 357(9264):1288-9. PubMed ID: 11421208
[No Abstract] [Full Text] [Related]
18. Letting the genome out of the bottle: prospects for new drug development.
Young D
Ann N Y Acad Sci; 2001 Dec; 953():146-50. PubMed ID: 11795407
[TBL] [Abstract][Full Text] [Related]
19. New generation methods for drug susceptibility testing for tuberculosis.
Katoch VM
Indian J Tuberc; 2008 Apr; 55(2):61-3. PubMed ID: 18516820
[No Abstract] [Full Text] [Related]
20. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
Tungusova OS; Mar'iandyshev AO
Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
[No Abstract] [Full Text] [Related]
[Next] [New Search]
